Celldex Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 CLDX shares in the last 100 trades.

Insider Power

(Last 100 transactions)
0
Buy 0 Shares
Sell 0 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 05, 2025 Incentive Stock Option (right to buy) Buy Cavanaugh Sarah 78 000
Jun 05, 2025 Incentive Stock Option (right to buy) Buy Crowley Elizabeth 85 000
Jun 05, 2025 Incentive Stock Option (right to buy) Buy Heath-chiozzi Margo 82 000
Jun 05, 2025 Incentive Stock Option (right to buy) Buy Jimenez Freddy A. 75 000
Jun 05, 2025 Incentive Stock Option (right to buy) Buy Martin Samuel Bates 81 000
Jun 05, 2025 Incentive Stock Option (right to buy) Buy Pepin Ronald 20 000
Jun 05, 2025 Incentive Stock Option (right to buy) Buy Young Diane C. 72 000
Jun 05, 2025 Incentive Stock Option (right to buy) Buy Keler Tibor 93 000
Jun 05, 2025 Incentive Stock Option (right to buy) Buy Marucci Anthony S 300 000
Jun 05, 2025 Non-Qualified Stock Option (right to buy) Buy Torres Denice 33 000
Jun 05, 2025 Non-Qualified Stock Option (right to buy) Buy Jain Rita 16 500
Jun 05, 2025 Non-Qualified Stock Option (right to buy) Buy Neil Garry Arthur 16 500
Jun 05, 2025 Non-Qualified Stock Option (right to buy) Buy Penner Harry Jr 16 500
Jun 05, 2025 Non-Qualified Stock Option (right to buy) Buy Conrad Herbert J 16 500
Jun 05, 2025 Non-Qualified Stock Option (right to buy) Buy Marino James J 16 500
Jun 05, 2025 Non-Qualified Stock Option (right to buy) Buy Brownlie Keith L 16 500
Jun 05, 2025 Non-Qualified Stock Option (right to buy) Buy Cohen Cheryl 16 500
Jun 05, 2025 Buy Torres Denice 0
Nov 18, 2024 Common Stock Buy Marino James J 10 500
Nov 11, 2024 Common Stock Buy Marucci Anthony S 11 500
Jun 14, 2024 Incentive Stock Option (Right to Buy) Buy Martin Samuel Bates 16 968
Jun 14, 2024 Common Stock Buy Martin Samuel Bates 16 968
Jun 14, 2024 Common Stock Buy Martin Samuel Bates 3 201
Jun 14, 2024 Common Stock Buy Martin Samuel Bates 17 172
Jun 14, 2024 Incentive Stock Option (Right to Buy) Buy Martin Samuel Bates 3 201
Click to get the best stock tips daily for free!
ABOUT CELLDEX THERAPEUTICS
Celldex Therapeutics
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity...
GOLDEN STAR
Ticker Change Signal Date
G
GTM
$9.57
2.40% Jun 02
TAC
$8.90
23.37% May 12
IMMR
$7.28
4.81% May 09
UAA
$5.84
20.38% May 09
MEDP
$300.81
2.84% May 08

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE